Jinxed mice by Bashyam, Hema
IN THIS ISSUE | The Journal of Experimental Medicine  697
Text by Hema Bashyam
hbashyam@rockefeller.edu
Jinxed mice
Mice with a newly identified germline mutation 
suggest that a fatal genetic disease in humans 
might be triggered by viral infection, according to 
Crozat et al. (page 853).
The mutated gene, called Unc13d, was identified 
in a screen for chemically induced mutations that 
make mice susceptible to murine cytomegalovirus 
(MCMV). Mutations in the Unc13d orthologue 
MUNC13-4 are associated with a severe human 
disease characterized by the uncontrolled 
proliferation of CD8+ T cells. These cells produce 
cytokines but fail to release cytotoxic granules, as 
MUNC13-4 is required for the fusion of granules 
with the plasma membrane.
The Unc13d-deficient mice, which the team called 
Jinx, also had the same degranulation defect in their 
CD8+ T cells. They did not, however, develop the fatal 
lymphoproliferative disease seen in humans unless 
they were also infected with lymphochoriomeningitis 
virus—a pathogen that elicits robust T cell expansion. 
MCMV infection did not cause the disease, probably 
because the mice succumbed too quickly to the virus.
The pathogenesis of the human disease has so far 
been unclear. This study now suggests that the disease 
is triggered in MUNC13-4–deficient humans after 
infection with a pathogen stimulates a strong but 
ultimately ineffective CD8+ T cell expansion. The T cells 
might prompt cytokine-driven expansion of virus-
infected APCs without killing them. The APCs, in turn, 
might drive further expansion of T cells, with each cell 
type stimulating the other in a vicious cycle. 
A parasite’s power play
On page 929, Ashton et al. report that an 
  intracellular parasite regulates its own growth 
and exploits the inflammatory environment 
within its host to continue its survival and 
mediate long-term damage.
Trypanosoma cruzi, the bug that causes 
Chagas’ disease, initiates a short-lived acute 
infection in humans. A third of those infected, 
however, develop chronic cardiac disease that 
sets in after a long asymptomatic period. The 
mechanism by which the parasite facilitates 
this long-term pathology is still unclear.
Ashton et al. now show that the parasite 
infects vascular endothelial cells and secretes 
a bioactive lipid called thromboxane (TXA2). 
When produced by human cells, TXA2 has 
pro-inflammatory effects and can cause 
cardiac injury by triggering platelet aggre-
gation, clotting, and vasoconstriction.
The parasitic TXA2 also promotes cardiac 
injury, the team finds, yet it somehow mediates 
an anti-inflammatory immune response in the 
host. Mice that lack cell surface receptors for 
TXA2 had increased inflammatory damage.
These mice also had a higher parasite load 
than wild-type mice, suggesting that the para-
site suppresses its own replication by a negative 
feedback through the TXA2 receptor. The 
group is now dissecting TXA2 receptor signal-
ing within infected cells to determine how the 
parasite controls its own growth rate.
The team speculates that, within infected 
cells, the parasite uses TXA2 to limit its 
own growth and minimize cell damage, thus 
ensuring its survival. But parasite-secreted 
TXA2 also engages receptors on uninfected 
host cells, which might eventually cause the 
heart disease seen in chronic infections. 
Mucosal HIV transmission
Sexually transmitted HIV begins its battle with the immune system 
in the mucosal tissues of the host gut. Sun et al. (page 705) now 
  recapitulate these events for the first time in a small animal model by 
replacing a mouse immune system with human lymphocytes.
Mice that lack their own T and B lymphocytes can be humanized by 
grafting them with human bone marrow, fetal liver, and fetal thymic 
tissue (BLT). This environment supports the development of human stem 
cells into various immune cell lineages, but it was not yet clear whether 
the cells were fully functional and homed to the appropriate tissues.
Sun and colleagues now use this system to show that human 
lymphocytes, including CD4+ T cells expressing the HIV corecep-
tors CCR5 and CXCR4, are able to migrate into the lymphoid 
tissues in the mouse gut and repopulate these areas. The mice were 
highly susceptible to intrarectal HIV infection, a common route 
of transmission. The mice displayed the same disease pathology as 
that seen in humans—systemic viral infec-
tion and CD4+ T cell depletion from their 
tissues—and even produced human antibodies 
against the virus.
This model offers a significant advantage 
over current primate models, which only 
permit infection with SIV or SIV/HIV chimeric 
viruses. “We finally have a way to follow HIV 
in a system that is as close to the human situa-
tion as you can get,” says senior author J. Victor 
Garcia. The researchers plan to test their 
model for susceptibility to intravaginal HIV 
infection and to understand how the virus 
traverses mucosal barriers. The mice should 
also be useful in preclinical screens for micro-
bicides, vaccines, and preventive drugs. 
T. cruzi (blue dots) thrives in cells 
lacking (bottom) TXA2 receptors.
Human CD4+ T cells 
(brown) repopulate 
mucosal tissues in 
humanized mice.